Form 0920-0134 Enhanced Data Collection During COVID-19 Pandemic

OMB Approved

Control No. 0920-0134

Exp. 3/31/2022

Enhanced Data Collection During COVID-19 Pandemic

**Please submit to [email protected] every Monday by 0900 EDT**

Directions: Enter new cases diagnosed from Monday 0000 EDT to Sunday 2359 EDT for each category as defined below.

Ship:
Date Submitted (mm/dd/yy):
Total # of crew members onboard:
Closest seaport at time of submission (City and Country):
Symptomatic Case Counts and Diagnostic Testing: Please ensure these counts are independent of each other (i.e., a person is not listed as both ILI and pneumonia)	Enter Numbers Below (Unless Otherwise Specified)
What is your ARI case count for the specified time period? (defined as the presence of cough, sore throat, or runny nose (rhinorrhea) in the absence of fever and in the absence of a non-infectious diagnosis as determined by the ship’s medical provider (e.g., allergies))
What is your ILI case count for the specified time period? (defined as fever (≥100.4 °F [38 °C]) plus either cough or sore throat)
What is your pneumonia case count for the specified time period?
What is your additional COVID-19-Like Illness (aCLI) case count for the specified time period? (additional CLI clinical criteria defined below) NOTE: If a person meets criteria for ARI, ILI, or pneumonia, please do not include them in this section. Additional CLI (aCLI) clinical criteria: At least two or more of the following symptoms: chills, rigors, muscle or body aches (myalgias), headache, fatigue, nasal congestion, vomiting, or diarrhea or At least one or more of the following symptoms: fever (without meeting ILI criteria or pneumonia diagnosis above), new loss of taste or smell, shortness of breath, or difficulty breathing
How many symptomatic persons were tested for influenza via rapid diagnostic test?
Of the symptomatic persons tested for influenza via rapid diagnostic test, how many tested positive?
How many symptomatic persons were tested for COVID-19 via PCR test? (do not include asymptomatic persons tested for routine screening or disembarkation and/or repatriation – see question below)
Of the symptomatic persons tested for COVID-19 via PCR test, how many tested positive?
Of the symptomatic persons tested for COVID-19 via PCR test, how many have pending results?
Of the symptomatic persons tested for COVID-19 via PCR test who had pending results in the previous EDC submission, how many of those were positive?
How many symptomatic persons were tested for COVID-19 via rapid antigen test? (do not include asymptomatic persons tested for routine screening or disembarkation and/or repatriation – see question below)
Of the symptomatic persons tested for COVID-19 via rapid antigen test, how many tested positive?
What brand of test was used?
How many symptomatic persons were tested for antibodies to coronavirus or COVID-19 via rapid serology* test? (do not include asymptomatic persons tested for routine screening or disembarkation and/or repatriation – see question below)
Of the symptomatic persons tested for antibodies to coronavirus or COVID-19 via rapid serology* test, how many tested positive?
What brand of test was used?
How many symptomatic persons needed hospitalization?
Of those hospitalized, how many required mechanical ventilation?
Of those hospitalized, how many were medically evacuated from the ship?
Please explain the reason for medevac(s).
Asymptomatic Case Counts and Diagnostic Testing:	Enter Numbers Below (Unless Otherwise Specified)
How many asymptomatic persons were tested for COVID-19 via PCR test for routine screening or disembarkation and/or repatriation (this includes testing (a) while onboard, (b) within 48 hours after disembarking, and (c) between 48 hours–7 days after disembarking)?
Of the asymptomatic persons tested for COVID-19 via PCR test for routine screening or disembarkation and/or repatriation, how many tested positive? (Note: Any positive test results from crew members who were tested between 48 hours–7 days after disembarking the ship should be reported to CDC by email (without personally identifiable information (PII)) to [email protected], not via EDC)**
Of the asymptomatic persons tested for COVID-19 via PCR test for routine screening or disembarkation and/or repatriation, how many have pending results?
Of the asymptomatic persons tested for COVID-19 via PCR test for routine screening or disembarkation and/or repatriation with pending results on the previous EDC submission, how many of those were positive? (Note: Any positive test results from crew members who were tested between 48 hours–7 days after disembarking the ship should be reported to CDC by email (without PII) to [email protected], not via EDC)**
How many asymptomatic persons were tested for COVID-19 via rapid antigen test for routine screening or disembarkation and/or repatriation (this includes testing while onboard, within 48 hours after disembarking, and between 48 hours–7 days after disembarking)?
Of the asymptomatic persons tested for COVID-19 via rapid antigen test for routine screening or disembarkation and/or repatriation, how many tested positive? (Note: Any positive test results from crew members who were tested between 48 hours–7 days after disembarking the ship should be reported to CDC by email (without PII) to [email protected], not via EDC)**
What brand of test was used?
How many asymptomatic persons were tested for antibodies to coronavirus or COVID-19 via rapid serology* test for routine screening or disembarkation and/or repatriation (this includes testing while onboard, within 48 hours after disembarking, or between 48 hours–7 days after disembarking)?
Of the asymptomatic persons tested for antibodies to coronavirus or COVID-19 via rapid serology* test for routine screening or disembarkation and/or repatriation, how many tested positive?
What brand of test was used?
Isolation Practices: Were persons with ARI, ILI, pneumonia, additional CLI symptoms, positive antigen results, or positive PCR results isolated for COVID-19 per CDC guidelines?¥

* CDC does not recommend the use of antibody testing to diagnose or screen for active COVID-19 infections, and FDA has not authorized antibody testing for diagnostic purposes.

** CDC will evaluate these positive results and may request additional information to determine if they should be included in the EDC case counts.

^¥ Persons with ILI, ARI, pneumonia, or additional CLI symptoms should be isolated using the same guidelines as a confirmed COVID-19 case.

Isolation may be discontinued for symptomatic crew with suspected or confirmed COVID-19 under conditions outlined at: www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-in-home-patients.html

Public reporting burden of this collection of information is estimated to take 13 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information.  An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB Control Number.  Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer, 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA 0920-0134.